| (11) | Number of the document | 4584 |
| (21) | Number of the application | a 2017 0006 |
| (22) | Filing date of the application | 2015.06.19 |
| | Date of filing the request for examination | (de fond) 12.01.2017 |
| (71) | Name(s) of applicant(s), code of the country | GILEAD SCIENCES, INC., US; |
| (72) | Name(s) of inventor(s), code of the country | CARRA Ernest A., US; CHEN Irene, US; ZIA Vahid, US; |
| (73) | Name(s) of owner(s), code of the country | GILEAD SCIENCES, INC., US; |
| (54) | Title of the invention | Sodium (2R,5S,13aR)-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-olate |
| (13) | Kind-of-document code | |
| (51) | International Patent Classification | C07D 498/14 (2006.01); A61K 31/535 (2006.01); A61P 31/18 (2006.01); |
| (19) | Country | US |
| (41) | Date of publication of the application | 2017.06.30 |
| (45) | Date of publication of patent granting decision: | 2018.07.31 |
| (47) | Date of issuance of patent | 2019.02.28 |
| (30) | Priority | 62/015245, 2014.06.20, US |
| (74) | Patent attorney | MARGINE Ion, Str. Lomonosov nr. 43, ap. 23, MD-2009, Chişinău, Republica Moldova |
| | Substantive examiner(s) | JOVMIR Tudor, GROSU Viorel |
| (85) | Date of introducing the national procedure | 2017.01.12 |
| (86) | International application | PCT/US2015/036757, 2015.06.19 |
| (87) | International publication | WO 2015/196116 A1, 2015.12.23 |
| | Payment for maintenance up to the date | 2024.06.19 |